Related Experiment Video
Updated: May 16, 2026

03:07
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
Current controversies in breast cancer surgery
A C Critchley1, A M Thompson, H Y Chan
1Royal Hallamshire Hospital, Sheffield, UK. adamcritchley@doctors.net.uk
Summary
Breast cancer surgery management is evolving. While sentinel lymph node biopsy may change axillary node dissection protocols, more evidence is needed. Optimal breast reconstruction choices balance patient expectations with surgical techniques.
Area of Science:
- Surgical Oncology
- Breast Cancer Management
- Reconstructive Surgery
Background:
- Axillary lymph node status is critical for breast cancer prognosis and adjuvant treatment decisions.
- Current breast cancer surgery guidelines are evolving, particularly regarding the management of positive sentinel nodes.
- Breast reconstruction rates are increasing, yet robust evidence comparing techniques and timing is limited.
Purpose of the Study:
- To review current controversies and evidence in axillary management for breast cancer.
- To explore the benefits and limitations of different breast reconstruction methods.
- To discuss the optimal timing and patient selection for breast reconstruction post-mastectomy.
Main Methods:
- Review of contemporary surgical management strategies for the breast cancer axilla.
- Analysis of evidence regarding sentinel lymph node biopsy versus axillary node dissection.
- Exploration of autologous, implant-based, and combined breast reconstruction techniques.
- Consideration of findings from the National Mastectomy and Breast Reconstruction Audit.
Main Results:
- The role of axillary node dissection following a positive sentinel node biopsy requires further investigation.
- Various oncoplastic and reconstructive techniques offer options, but evidence comparing them is scarce.
- Patient satisfaction is maximized when reconstruction aligns with individual expectations.
Conclusions:
- Management of the breast cancer axilla is in transition, necessitating further research before altering established protocols.
- Selecting the optimal breast reconstruction type and timing is crucial for patient satisfaction.
- Further randomized trials are needed to guide evidence-based decisions in breast cancer surgery and reconstruction.